HCP
TMO icon

Hexagon Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Hexagon Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
485
+13
+3% +$6.24K 0.03% 230
2026
Q1 		$232K Buy
+472
New +$256K 0.03% 226
2025
Q2 		– Sell
-521
Closed -$259K – 1561
2025
Q1 		$259K Sell
521
-129
-20% -$69.9K 0.05% 178
2024
Q4 		$338K Buy
650
+151
+30% +$83K 0.06% 139
2024
Q3 		$309K Sell
499
-14
-3% -$8.29K 0.06% 150
2024
Q2 		$284K Buy
513
+3
+0.6% +$1.72K 0.06% 154
2024
Q1 		$296K Sell
510
-45
-8% -$25.3K 0.07% 149
2023
Q4 		$295K Buy
555
+6
+1% +$2.9K 0.07% 143
2023
Q3 		$278K Sell
549
-9
-2% -$4.8K 0.07% 128
2023
Q2 		$291K Sell
558
-34
-6% -$18.3K 0.08% 124
2023
Q1 		$341K Sell
592
-1
-0.2% -$564 0.1% 105
2022
Q4 		$327K Sell
593
-111
-16% -$58.8K 0.1% 107
2022
Q3 		$357K Sell
704
-42
-6% -$23.5K 0.11% 101
2022
Q2 		$405K Buy
746
+91
+14% +$50.1K 0.12% 101
2022
Q1 		$387K Sell
655
-12
-2% -$6.89K 0.1% 115
2021
Q4 		$445K Sell
667
-22
-3% -$13.7K 0.12% 101
2021
Q3 		$394K Sell
689
-29
-4% -$15.9K 0.11% 97
2021
Q2 		$362K Sell
718
-46
-6% -$21.7K 0.1% 103
2021
Q1 		$348K Sell
764
-263
-26% -$126K 0.1% 96
2020
Q4 		$478K Buy
1,027
+68
+7% +$31.9K 0.14% 65
2020
Q3 		$460K Buy
+959
New +$396K 0.15% 66

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Hexagon Capital Partners's TMO Position: Q2 2026 in Review

Hexagon Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 2.8% in Q2 2026, buying an estimated $6.24K and bringing the position to 485 shares worth $243K. The position accounts for 0.03% of the portfolio, ranked #230.

Hexagon Capital Partners first reported a position in TMO in Q3 2020 and has held it in 21 quarters since. The position peaked at $478K in Q4 2020. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Hexagon Capital Partners held 485 shares of Thermo Fisher Scientific worth $243K as of Q2 2026.
  • Hexagon Capital Partners bought 13 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.24K.
  • Thermo Fisher Scientific made up 0.03% of Hexagon Capital Partners's portfolio in Q2 2026, its #230 holding.
  • Hexagon Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 21 quarters since.
  • Hexagon Capital Partners's Thermo Fisher Scientific position peaked at $478K in Q4 2020.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Hexagon Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.